Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.
30 Gennaio 2025 - 2:30PM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to
release its fourth quarter and fiscal year 2024 financial results
after market close on Thursday, February 13, 2025. Management will
hold a conference call to review the company's fourth quarter and
fiscal year 2024 performance starting at 4:30 p.m. (Eastern Time)
on the same day. The conference call will be concurrently webcast.
The link to the webcast will be available on the Dexcom investor
relations website at investors.dexcom.com and will be archived
there for future reference.
To listen to the conference call, please dial (888) 414-4585
(US/Canada) or (646) 960-0331 (International) and use the
confirmation ID "9430114" approximately five minutes prior to the
start time.
About DexCom, Inc.
Dexcom empowers people to take control of health through
innovative biosensing technology. Founded in 1999, Dexcom has
pioneered and set the standard in glucose biosensing for more than
25 years. Its technology has transformed how people manage diabetes
and track their glucose, helping them feel more in control and live
more confidently.
Dexcom. Discover what you’re made of. For more information,
visit www.dexcom.com.
Category: IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250130188254/en/
DexCom, Inc.: Sean Christensen Vice President – Finance
and Investor Relations investor-relations@dexcom.com (858)
200-0200
Grafico Azioni DexCom (NASDAQ:DXCM)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni DexCom (NASDAQ:DXCM)
Storico
Da Mar 2024 a Mar 2025
